Skip to main content
Tweets by IDWeek 2021
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Wednesday, September 29, 2021
13 - The Efficacy and Effectiveness of Pneumococcal Vaccines against Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis
21 - Systematic Review and Meta-Analysis of Pneumococcal Vaccine Effectiveness against Invasive Pneumococcal Disease among Adults
117 - How Does Antimicrobial Stewardship Provider Role Affect Prospective Audit and Feedback Acceptance by the Attending Physician?
Bacteremia Management and Outcomes Following Infectious Disease Consult Over Time at a Tertiary Care Center in Canada
Long COVID in Cancer patients: Preponderance of Symptoms in Majority of Patients over Long Time Period
375 - High laboratory-confirmed SARS-CoV-2 attack rate in Lima health care personnel during August 2020-March 2021 suggests role for improved infection control
397 - Impact of School Opening Model on Cases of SARS-CoV-2 in Surrounding Communities: A Nationwide, Retrospective Cohort Study
688 - Incidence and Risk Factors for Prosthetic Valve Endocarditis Following TAVR: 2015-2019
- Approaches to Optimize Recruitment of Historically Underrepresented Black and Hispanic/LatinX MSM, Transgender, and Gender Non-binary Individuals into the Lenacapavir for PrEP (PURPOSE 2) Trial
996 - CD4+ T-Cell Lymphopenia Associated with Frequent Plateletpheresis in Healthy Donors
1055 - ARGONAUT-IV: Susceptibility of Carbapenem-resistant
1063 - ARGONAUT-V: Susceptibility of multidrug-resistant (MDR)
1140 - Impact of a Rapid Molecular Bloodstream Diagnostic Test on Optimal Antibiotic Use in Infants
1286 - Taniborbactam Inhibits Cefepime-Hydrolyzing Variants of
-derived Cephalosporinase (PDC)
1299 - Epidemiology of Invasive Pneumococcal Disease (IPD) in the United States 2011-2019
1331 - Seasonality of Common Human Coronaviruses in the United States, 2014-2021
1332 - Clinical indicators for when bronchoalveolar lavage (BAL) is needed beyond nasopharyngeal swab (NP) testing for viral respiratory infections
Durlobactam, a Diazabicyclooctane (DBO) β-lactamase Inhibitor (BLI), Inhibits BlaC and Peptidoglycan (PG) Transpeptidases of
Mycobacterium tuberculosis (Mtb)
: A Novel Approach to Therapeutics for Tuberculosis (TB)?
Back to Top